TORONTO, March 27, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology...
TORONTO, March 11, 2024 (GLOBE NEWSWIRE) — Further to the announcement by Psyence Group Inc (“Psyence Group” or the “Company“) (CSE:PSYG) of...
In a landmark study on the “moral status” of psilocybin, nearly 9 out of 10 Americans have voiced their approval for the controlled, licensed use of...
At the forefront of medical innovation, the Cleveland Clinic is pioneering a study that revisits the potential of psychedelics, substances traditionally...
The new Nasdaq-listed entity trades under the ticker symbol PBM. The post Australia approves Psyence phase 2b study as it finalizes merger appeared first...
He had it suspended last May and his stores were raided by police in November, but it appears his perseverance has paid off The post Controversial...
The Energia Foundation and Tabula Rasa Ventures, notable for introducing psychedelic education at Davos in 2022, have been at the forefront of bringing...
The Energia Foundation and Tabula Rasa Ventures, notable for introducing psychedelic education at Davos in 2022, have been at the forefront of bringing...
The JAMA (Journal of American Medical Association) Psychiatry published an article calling for more research and surveillance of ketamine treatments. Citing...
The company is still reeling with negative cash flows and net losses. The post Mynd Life Sciences cuts losses, but faces going concern doubts appeared...
In recent years, the term “psilocybin gummies” and related search queries have seen a significant uptick on Google, signaling a marked increase in...
In recent years, the term “psilocybin gummies” and related search queries have seen a significant uptick on Google, signaling a marked increase in...
VANCOUVER, BC / ACCESSWIRE / March 4, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the “Company” or “MindBio“) is pleased to...
VANCOUVER, British Columbia, March 04, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF /...
NEW YORK and BERLIN, March 04, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical...
A groundbreaking study by Northwestern Medicine has unveiled the intricate processes that enable ketamine to produce both immediate and enduring antidepressant...